Sulfonamidolactam inhibitors of coagulation factor Xa
摘要:
As part of an effort to identify novel backups for previously reported pyrazole-based coagulation Factor Xa inhibitors, the pyrazole 5-carboxamide moiety was replaced by 3-(sulfonylamino)-2-piperidone. This led to the identification of a structurally diverse chemotype that was further optimized to incorporate neutral or weakly basic aryl and heteroaryl P1 groups while maintaining good potency versus Factor Xa. Substitution at the sulfonamide nitrogen provided further improvements in potency and as did introduction of alternate P4 moieties. (C) 2008 Elsevier Ltd. All rights reserved.
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
申请人:——
公开号:US20040006062A1
公开(公告)日:2004-01-08
The present application describes sulfonylaminovalerolactams and derivatives thereof of Formula I:
1
or pharmaceutically acceptable salt forms thereof, wherein ring G is a mono- or bicyclic carbocycle or heterocycle. Compounds of the present invention are useful as inhibitors of trypsin-like serine proteases, specifically factor Xa.